{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T01:16:05Z","timestamp":1794446165670,"version":"4.9.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"DOI":"10.1186\/s12981-026-00860-x","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T11:59:44Z","timestamp":1770983984000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Incidence and predictors of loss to follow-up among adults on antiretroviral therapy in Ethiopia: a systematic review and meta-analysis of cohort studies"],"prefix":"10.1186","volume":"23","author":[{"given":"Muluken Amare","family":"Wudu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsegenet Arega","family":"Asmamaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fantawork Samuel","family":"Mojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selamyhun Tadesse","family":"Yosef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aragaw Tesfaye","family":"Gelmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimer Seid","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarikua Afework","family":"Birhanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"key":"860_CR1","unstructured":"World health statistics. 2024: monitoring health for the SDGs, Sustainable Development Goals. Geneva: World Health Organization; 2024. (CC BY-NC-SA 3.0 IGO. https:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/igo."},{"key":"860_CR2","unstructured":"The path that ends AIDS: UNAIDS Global AIDS update 2023. 3.0 IGO. Joint united nations programme on HIV\/AIDS. Geneva: Licence: CC BY-NC-SA; 2023."},{"key":"860_CR3","unstructured":"HIV. The global health observatory [online database]. Geneva: World Health Organization. https:\/\/www.who.int\/data\/gho\/data\/themes\/hiv-aids"},{"key":"860_CR4","unstructured":"World Health Organization. WHO Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. 2015.4."},{"issue":"9","key":"860_CR5","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMoa16006937","volume":"375","author":"MS Cohen","year":"2016","unstructured":"Cohen MS, Chen YQ, McCauley M, et al. Antiretroviral therapy for the prevention of HIV-1 transmission. N Engl J Med. 2016;375(9):830\u20139. https:\/\/doi.org\/10.1056\/NEJMoa16006937.","journal-title":"N Engl J Med"},{"key":"860_CR6","first-page":"1512","volume":"4","author":"Centers for Disease Control and Prevention","year":"2018","unstructured":"Centers for Disease Control and Prevention. Evidence of HIV treatment and viral suppression in preventing the sexual transmission of HIV. Dep Heal Hum Serv. 2018;4:1512.","journal-title":"Dep Heal Hum Serv"},{"issue":"1","key":"860_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2458-13-8678","volume":"13","author":"I Ahmed","year":"2013","unstructured":"Ahmed I, Gugsa ST, Lemma S, et al. Predictors of loss to follow-up before HIV treatment initiation in Northwest ethiopia: a case control study. BMC Public Health. 2013;13(1):1\u20139. https:\/\/doi.org\/10.1186\/1471-2458-13-8678.","journal-title":"BMC Public Health"},{"key":"860_CR8","unstructured":"FMOH Ethiopia. Pocket Guide. National guidelines for comprehensive HIV prevention care and management. Ethiopia Fed Ministry Health.2022;1\u201336. https:\/\/scholar.google.com\/scholar?hl=en&as_sdt=0%2C5&q=Pocket+Guide.National+guidelines+for+comprehensive+HIV+prevention+care+and+manangement%2C"},{"key":"860_CR9","unstructured":"World Health Organization (WHO). Global Report on Early Warning Indicators of HIV Drug Resistance: Technical Report. World Health Organization. 2016. https:\/\/apps.who.int\/iris\/handle\/10665\/246219"},{"key":"860_CR10","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/QAI.0000000000000553","volume":"69","author":"MP Fox","year":"2015","unstructured":"Fox MP. Retention of adult patients on antiretroviral therapy in low and middle-income countries: systematic review and meta-analysis 2008\u20132013. J Acquir Immune Defic Syndr. 2015;69:98. https:\/\/doi.org\/10.1097\/QAI.0000000000000553.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"860_CR11","doi-asserted-by":"publisher","first-page":"21682","DOI":"10.3402\/gha.v6i0.21682","volume":"6","author":"G Alvarez-Uria","year":"2013","unstructured":"Alvarez-Uria G, Naik PK, Pakam R, Midde M. Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India. Glob Health Action. 2013;6:21682. https:\/\/doi.org\/10.3402\/gha.v6i0.21682.","journal-title":"Glob Health Action"},{"key":"860_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-015-0912-2","volume":"15","author":"MN Mberi","year":"2015","unstructured":"Mberi MN, Kuonza LR, Dube NM, Nattey C, Manda S, Summers R. Determinants of loss to follow-up in patients on antiretroviral treatment, South Africa, 2004\u20132012: a cohort study. BMC Health Serv Res. 2015;15:1\u201311. https:\/\/doi.org\/10.1186\/s12913-015-0912-2.","journal-title":"BMC Health Serv Res"},{"key":"860_CR13","doi-asserted-by":"crossref","unstructured":"Webb S. A retrospective notes-based review of patients lost to follow-up from anti-retroviral therapy at Mulanje mission Hospital, Malawi. MalawiMed J. 2018;30:73\u20138.","DOI":"10.4314\/mmj.v30i2.4"},{"key":"860_CR14","doi-asserted-by":"publisher","first-page":"e0217606","DOI":"10.1371\/journal.pone.0217606","volume":"15","author":"J Kiwanuka","year":"2020","unstructured":"Kiwanuka J, Mukulu Waila J, Muhindo Kahungu M, Kitonsa J, Kiwanuka N. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda. PLoS ONE. 2020;15:e0217606. https:\/\/doi.org\/10.1371\/journal.pone.0217606.","journal-title":"PLoS ONE"},{"issue":"393","key":"860_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4172\/2155-6113.1000393","volume":"5","author":"K Tadesse","year":"2014","unstructured":"Tadesse K, Fisiha H. Predictors of loss to follow up of patients enrolled on antiretroviral therapy: a retrospective cohort study. J AIDS Clin Res. 2014;5(393):2. https:\/\/doi.org\/10.4172\/2155-6113.1000393.","journal-title":"J AIDS Clin Res"},{"issue":"9","key":"860_CR16","doi-asserted-by":"publisher","first-page":"453","DOI":"10.4103\/1947-2714.141636","volume":"6","author":"TM Berheto","year":"2014","unstructured":"Berheto TM, Haile DB, Mohammed S. Predictors of loss to follow-up in patients living with HIV\/AIDS after initiation of antiretroviral therapy. North Am J Med Sci. 2014;6(9):453. https:\/\/doi.org\/10.4103\/1947-2714.141636.","journal-title":"North Am J Med Sci"},{"key":"860_CR17","doi-asserted-by":"publisher","unstructured":"Teshome W, Belayneh M, Moges M, Mekonnen E, Endrias M, Ayele S, Misganaw T, Shiferaw M, Tesema T. Do loss to follow-up and death rates from ART care vary across primary health care facilities and hospitals in South ethiopia? A retrospective follow-up study. HIV\/AIDS-Research and palliative care. 2015; 28:167\u201374. https:\/\/doi.org\/10.2147\/HIV.S85440","DOI":"10.2147\/HIV.S85440"},{"issue":"3","key":"860_CR18","doi-asserted-by":"publisher","first-page":"e000325","DOI":"10.1136\/bmjgh-2017-000325","volume":"2","author":"R Bucciardini","year":"2017","unstructured":"Bucciardini R, Fragola V, Abegaz T, Lucattini S, Halifom A, Tadesse E, Berhe M, Pugliese K, Fucili L, Di Gregorio M, Mirra M. Predictors of attrition from care at 2 years in a prospective cohort of HIV-infected adults in Tigray, Ethiopia. BMJ Global Health. 2017;2(3):e000325. https:\/\/doi.org\/10.1136\/bmjgh-2017-000325.","journal-title":"BMJ Global Health"},{"key":"860_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-018-3407-5","volume":"11","author":"MA Assemie","year":"2018","unstructured":"Assemie MA, Muchie KF, Ayele TA. Incidence and predictors of loss to follow up among HIV-infected adults at Pawi general Hospital, Northwest ethiopia: competing risk regression model. BMC Res Notes. 2018;11:1\u20136. https:\/\/doi.org\/10.1186\/s13104-018-3407-5.","journal-title":"BMC Res Notes"},{"key":"860_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-018-3188-4","volume":"18","author":"W Seifu","year":"2018","unstructured":"Seifu W, Ali W, Meresa B. Predictors of loss to follow up among adult clients attending antiretroviral treatment at Karamara general hospital, Jigjiga town, Eastern Ethiopia, 2015: a retrospective cohort study. BMC Infect Dis. 2018;18:1\u20138. https:\/\/doi.org\/10.1186\/s12879-018-3188-4.","journal-title":"BMC Infect Dis"},{"key":"860_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-019-3756-2","volume":"19","author":"KE Gezae","year":"2019","unstructured":"Gezae KE, Abebe HT, Gebretsadik LG. Incidence and predictors of LTFU among adults with TB\/HIV co-infection in two governmental hospitals, Mekelle, Ethiopia, 2009\u20132016: survival model approach. BMC Infect Dis. 2019;19:1\u20139. https:\/\/doi.org\/10.1186\/s12879-019-3756-2.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"860_CR22","first-page":"2456","volume":"8","author":"TE Gebre","year":"2019","unstructured":"Gebre TE, Bekele A. Attrition rate and predictors among adult patients receiving antiretroviral therapy in Adama Hospital Medical College, Central Ethiopia: a retrospective cohort study design, 2006\u20132017. Int J Adv res publ. 2019;8(3):2456\u20139992.","journal-title":"Int J Adv res publ"},{"key":"860_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-019-4154-y","volume":"12","author":"N Mekonnen","year":"2019","unstructured":"Mekonnen N, Abdulkadir M, Shumetie E, Baraki AG, Yenit MK. Incidence and predictors of loss to follow-up among HIV infected adults after initiation of first line anti-retroviral therapy at university of Gondar comprehensive specialized hospital Northwest Ethiopia, 2018: retrospective follow up study. BMC Res Notes. 2019;12:1\u20137. https:\/\/doi.org\/10.1186\/s13104-019-4154-y.","journal-title":"BMC Res Notes"},{"issue":"1","key":"860_CR24","doi-asserted-by":"publisher","first-page":"e0227473","DOI":"10.1371\/journal.pone.0227473","volume":"15","author":"AB Teshale","year":"2020","unstructured":"Teshale AB, Tsegaye AT, Wolde HF. Incidence and predictors of loss to follow up among adult HIV patients on antiretroviral therapy in university of Gondar comprehensive specialized hospital: A competing risk regression modeling. PLoS ONE. 2020;15(1):e0227473. https:\/\/doi.org\/10.1371\/journal.pone.0227473.","journal-title":"PLoS ONE"},{"issue":"9","key":"860_CR25","doi-asserted-by":"publisher","first-page":"e0239013","DOI":"10.1371\/journal.pone.0239013","volume":"15","author":"YT Hibstie","year":"2020","unstructured":"Hibstie YT, Kibret GD, Talie A, Temesgen B, Melkamu MW, Alebel A. Nearly one in every six HIV-infected children lost from ART follow-up at Debre Markos referral Hospital, Northwest ethiopia: A 14-year retrospective follow-up study. PLoS ONE. 2020;15(9):e0239013. https:\/\/doi.org\/10.1371\/journal.pone.0239013.","journal-title":"PLoS ONE"},{"key":"860_CR26","doi-asserted-by":"publisher","unstructured":"Bikoro B, Oljira L, Gobena T, Erkalo D. Incidence and predictors of loss to follow-up among human immunodeficiency virus-infected adult patients on anti-retroviral therapy at Hadiya zone public hospitals, Southern ethiopia: a retrospective cohort study. J Public Health. 2020;1\u20132. https:\/\/doi.org\/10.1007\/s10389-020-01268-1.","DOI":"10.1007\/s10389-020-01268-1"},{"key":"860_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41182-020-00266-z","volume":"48","author":"MY Birhanu","year":"2020","unstructured":"Birhanu MY, Leshargie CT, Alebel A, Wagnew F, Siferih M, Gebre T, Kibret GD. Incidence and predictors of loss to follow-up among HIV-positive adults in Northwest ethiopia: a retrospective cohort study. Trop Med Health. 2020;48:1\u20130. https:\/\/doi.org\/10.1186\/s41182-020-00266-z.","journal-title":"Trop Med Health"},{"key":"860_CR28","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2147\/HIV.S304657","volume":"20","author":"D Dejen","year":"2021","unstructured":"Dejen D, Jara D, Yeshanew F, Fentaw Z, Mengie Feleke T, Girmaw F, Wagaye B. Attrition and its predictors among adults receiving first-line antiretroviral therapy in Woldia town public health facilities, Northeast ethiopia: a retrospective cohort study. HIV\/AIDS-Research Palliat Care. 2021;20:445\u201354. https:\/\/doi.org\/10.2147\/HIV.S304657.","journal-title":"HIV\/AIDS-Research Palliat Care"},{"issue":"1","key":"860_CR29","doi-asserted-by":"publisher","first-page":"86593721","DOI":"10.1155\/2021\/8659372","volume":"2021","author":"MA Gebremichael","year":"2021","unstructured":"Gebremichael MA, Gurara MK, Weldehawaryat HN, Mengesha MM, Berbada DA. Predictors of loss to Follow-Up among HIV\u2010Infected adults after initiation of the First\u2010Line antiretroviral therapy at Arba minch general Hospital, Southern ethiopia: A 5\u2010Year retrospective cohort study. Biomed Res Int. 2021;2021(1):86593721\u201312. https:\/\/doi.org\/10.1155\/2021\/8659372.","journal-title":"Biomed Res Int"},{"key":"860_CR30","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2147\/HIV.S296226","volume":"17","author":"S Dessu","year":"2021","unstructured":"Dessu S, Mesele M, Habte A, Dawit Z. Time until loss to follow-up, incidence, and predictors among adults taking ART at public hospitals in Southern Ethiopia. HIV\/AIDS-Research Palliat Care. 2021;17:205\u201315.","journal-title":"HIV\/AIDS-Research Palliat Care"},{"key":"860_CR31","unstructured":"Argaw GS, Mariyam AA, Baraki AG, Birhan TY. Incidence and determinants of attrition among HIV infected patients receiving antiretroviral therapy in Dessie referral Hospital, ethiopia: retrospective follow up study. ISSN: 2155\u20136113."},{"key":"860_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e11527","author":"B Bantie","year":"2022","unstructured":"Bantie B, Abate MW, Nigat AB, Birlie TA, Dires T, Minuye T, Kerebeh G, Tiruneh CM, Moges N, Chanie ES, Feleke DG Attrition rate and its predictors among adults receiving anti-retroviral therapy following the implementation of the universal test and treat strategy at public health institutions in Northern Ethiopia. A retrospective follow-up study. Heliyon. 2022. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e11527.","journal-title":"Heliyon"},{"issue":"2","key":"860_CR33","doi-asserted-by":"publisher","first-page":"12","DOI":"10.4314\/ahs.v22i2.3","volume":"22","author":"WS Shiferaw","year":"2022","unstructured":"Shiferaw WS, Belete AM, Adela A, Getnet M, Aynalem YA. Incidence and predictors of loss to follow-up among adult HIV-infected patients taking antiretroviral therapy at North Shewa zone public Hospitals, Northeast ethiopia: A retrospective follow-up study. Afri Health Sci. 2022;22(2):12\u201326. https:\/\/doi.org\/10.4314\/ahs.v22i2.3.","journal-title":"Afri Health Sci"},{"issue":"1","key":"860_CR34","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1038\/s41598-022-07049-y","volume":"12","author":"AT Telayneh","year":"2022","unstructured":"Telayneh AT, Tesfa M, Woyraw W, Temesgen H, Alamirew NM, Haile D, Tafere Y, Petrucka P. Time to lost to follow-up and its predictors among adult patients receiving antiretroviral therapy retrospective follow-up study Amhara Northwest Ethiopia. Sci Rep. 2022;12(1):2916. https:\/\/doi.org\/10.1038\/s41598-022-07049-y","journal-title":"Sci Rep"},{"key":"860_CR35","doi-asserted-by":"publisher","first-page":"876430","DOI":"10.3389\/fpubh.2022.876430","volume":"10","author":"B Bantie","year":"2022","unstructured":"Bantie B, Seid A, Kerebeh G, Alebel A, Dessie G. Loss to follow-up in test and treat era and its predictors among HIV-positive adults receiving ART in Northwest ethiopia: Institution-based cohort study. Front Public Health. 2022;10:876430. https:\/\/doi.org\/10.3389\/fpubh.2022.876430.","journal-title":"Front Public Health"},{"issue":"3","key":"860_CR36","doi-asserted-by":"publisher","first-page":"227990362311971","DOI":"10.1177\/22799036231197194","volume":"12","author":"S Kassa","year":"2023","unstructured":"Kassa S, Dingeta T, Gobana T, Dufera T. Incidence and predictors of attrition among adults receiving first line anti-retroviral therapy at public health facility in Adea Berga district, Oromia, Ethiopia. J Public Health Res. 2023;12(3):22799036231197194. https:\/\/doi.org\/10.1177\/22799036231197194. 15.","journal-title":"J Public Health Res"},{"key":"860_CR37","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.2147\/JMDH.S414194","volume":"31","author":"S Zeleke","year":"2023","unstructured":"Zeleke S, Demis S, Eshetie Y, Kefale D, Tesfahun Y, Munye T, Kassaw A. Incidence and predictors of loss to follow-up among adults on antiretroviral therapy in South Gondar governmental hospitals, ethiopia: retrospective cohort study. J Multidisciplinary Healthc. 2023;31:1737\u201348. https:\/\/doi.org\/10.2147\/JMDH.S414194.","journal-title":"J Multidisciplinary Healthc"},{"key":"860_CR38","doi-asserted-by":"publisher","first-page":"1374515","DOI":"10.3389\/fpubh.2024.1374515","volume":"12","author":"A Anulo","year":"2024","unstructured":"Anulo A, Girma A, Tesfaye G, Asefa F, Cheru A, Lonsako AA. Incidence and predictors of loss to follow-up among adult patients receiving antiretroviral therapy in central ethiopia: a multi-center retrospective cohort study. Front Public Health. 2024;12:1374515. https:\/\/doi.org\/10.3389\/fpubh.2024.1374515.","journal-title":"Front Public Health"},{"issue":"1","key":"860_CR39","doi-asserted-by":"publisher","first-page":"17897","DOI":"10.1038\/s41598-021-97466-2","volume":"11","author":"E Nacarapa","year":"2021","unstructured":"Nacarapa E, Verdu ME, Nacarapa J, Macuacua A, Chongo B, Osorio D, Munyangaju I, Mugabe D, Paredes R, Chamarro A, Revollo B. Predictors of attrition among adults in a rural HIV clinic in Southern mozambique: 18-year retrospective study. Sci Rep. 2021;11(1):17897. https:\/\/doi.org\/10.1038\/s41598-021-97466-2.","journal-title":"Sci Rep"},{"issue":"4","key":"860_CR40","doi-asserted-by":"publisher","first-page":"e0217606","DOI":"10.1371\/journal.pone.0217606","volume":"15","author":"J Kiwanuka","year":"2020","unstructured":"Kiwanuka J, Mukulu Waila J, Muhindo Kahungu M, Kitonsa J, Kiwanuka N. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda. PLoS ONE. 2020;15(4):e0217606. https:\/\/doi.org\/10.1371\/journal.pone.0217606.","journal-title":"PLoS ONE"},{"issue":"12","key":"860_CR41","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1089\/apc.2012.0439","volume":"27","author":"R Guy","year":"2013","unstructured":"Guy R, Wand H, McManus H, Vonthanak S, Woolley I, Honda M, Read T, Sirisanthana T, Zhou J. Carr, on behalf of Australia HIV observational database A. Antiretroviral treatment interruption and loss to follow-up in two HIV cohorts in Australia and asia: implications for \u2018test and treat\u2019prevention strategy. AIDS Patient Care STDs. 2013;27(12):681\u201391. https:\/\/doi.org\/10.1089\/apc.2012.0439.","journal-title":"AIDS Patient Care STDs"},{"issue":"6","key":"860_CR42","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/hiv.12605","volume":"19","author":"S Nimkar","year":"2018","unstructured":"Nimkar S, Valvi C, Kadam D, Rewari BB, Kinikar A, Gupte N, Suryavanshi N, Deluca A, Shankar A, Golub J, Bollinger R. Loss to follow-up and mortality among HIV\u2010infected adolescents receiving antiretroviral therapy in Pune, India. HIV Med. 2018;19(6):395\u2013402. https:\/\/doi.org\/10.1111\/hiv.12605.","journal-title":"HIV Med"},{"issue":"7","key":"860_CR43","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/hiv.12734","volume":"20","author":"A Jiamsakul","year":"2019","unstructured":"Jiamsakul A, Kiertiburanakul S, Ng OT, Chaiwarith R, Wong W, Ditangco R, Nguyen KV, Avihingsanon A, Pujari S, Do CD, Lee MP. Long-term loss to follow\u2010up in the TREAT Asia HIV observational database (TAHOD). HIV Med. 2019;20(7):439\u201349. https:\/\/doi.org\/10.1111\/hiv.12734.","journal-title":"HIV Med"},{"issue":"10","key":"860_CR44","doi-asserted-by":"publisher","first-page":"e036136","DOI":"10.1136\/bmjopen-2019-036136","volume":"10","author":"Z Matsena Zingoni","year":"2020","unstructured":"Matsena Zingoni Z, Chirwa T, Todd J, Musenge E. Competing risk of mortality on loss to follow-up outcome among patients with HIV on ART: a retrospective cohort study from the Zimbabwe National ART programme. BMJ Open. 2020;10(10):e036136. https:\/\/doi.org\/10.1136\/bmjopen-2019-036136.","journal-title":"BMJ Open"},{"issue":"1","key":"860_CR45","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12879-023-08063-9","volume":"23","author":"SE Mushy","year":"2023","unstructured":"Mushy SE, Mtisi E, Mboggo E, Mkawe S, Yahya-Malima KI, Ndega J, Ngalesoni F, Muya A. Predictors of the observed high prevalence of loss to follow-up in ART-experienced adult PLHIV: a retrospective longitudinal cohort study in the Tanga Region, Tanzania. BMC Infect Dis. 2023;23(1):92. https:\/\/doi.org\/10.1186\/s12879-023-08063-9.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"860_CR46","doi-asserted-by":"publisher","first-page":"21682","DOI":"10.3402\/gha.v6i0.21682","volume":"6","author":"G Alvarez-Uria","year":"2013","unstructured":"Alvarez-Uria G, Naik PK, Pakam R, Midde M. Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India. Global Health Action. 2013;6(1):21682. https:\/\/doi.org\/10.3402\/gha.v6i0.21682.","journal-title":"Global Health Action"},{"issue":"1","key":"860_CR47","doi-asserted-by":"publisher","first-page":"e0188488","DOI":"10.1371\/journal.pone.0188488","volume":"13","author":"H Tweya","year":"2018","unstructured":"Tweya H, Oboho IK, Gugsa ST, Phiri S, Rambiki E, Banda R, Mwafilaso J, Munthali C, Gupta S, Bateganya M, Maida A. Loss to follow-up before and after initiation of antiretroviral therapy in HIV facilities in Lilongwe, Malawi. PLoS ONE. 2018;13(1):e0188488. https:\/\/doi.org\/10.1371\/journal.pone.0188488.","journal-title":"PLoS ONE"},{"issue":"8","key":"860_CR48","doi-asserted-by":"publisher","first-page":"e0272906","DOI":"10.1371\/journal.pone.0272906","volume":"17","author":"CT Leshargie","year":"2022","unstructured":"Leshargie CT, Demant D, Burrowes S, Frawley J. The proportion of loss to follow-up from antiretroviral therapy (ART) and its association with age among adolescents living with HIV in sub-Saharan africa: A systematic review and meta-analysis. PLoS ONE. 2022;17(8):e0272906. https:\/\/doi.org\/10.1371\/journal.pone.0272906.","journal-title":"PLoS ONE"},{"issue":"2","key":"860_CR49","doi-asserted-by":"publisher","first-page":"ofu055","DOI":"10.1093\/ofid\/ofu055","volume":"1","author":"ST Meloni","year":"2014","unstructured":"Meloni ST, Chang C, Chaplin B, Rawizza H, Jolayemi O, Banigbe B, Okonkwo P, Kanki P. Time-dependent predictors of loss to follow-up in a large HIV treatment cohort in Nigeria. In open forum infectious diseases. Oxf Univ Press. 2014;1(2):ofu055. https:\/\/doi.org\/10.1093\/ofid\/ofu055.","journal-title":"Oxf Univ Press"},{"issue":"1","key":"860_CR50","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12879-023-08063-9","volume":"23","author":"SE Mushy","year":"2023","unstructured":"Mushy SE, Mtisi E, Mboggo E, Mkawe S, Yahya-Malima KI, Ndega J, Ngalesoni F, Muya A. Predictors of the observed high prevalence of loss to follow-up in ART-experienced adult PLHIV: a retrospective longitudinal cohort study in the Tanga Region, Tanzania. BMC Infect Dis. 2023;23(1):92. https:\/\/doi.org\/10.1186\/s12879-023-08063-9. 23:92.","journal-title":"BMC Infect Dis"},{"key":"860_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-020-8426-1","volume":"20","author":"P Wekesa","year":"2020","unstructured":"Wekesa P, McLigeyo A, Owuor K, Mwangi J, Nganga E, Masamaro K. Factors associated with 36-month loss to follow-up and mortality outcomes among HIV-infected adults on antiretroviral therapy in central Kenya. BMC Public Health. 2020;20:1\u20131. https:\/\/doi.org\/10.1186\/s12889-020-8426-1.","journal-title":"BMC Public Health"},{"key":"860_CR52","doi-asserted-by":"publisher","first-page":"21843","DOI":"10.7448\/IAS.20.1.21843","volume":"20","author":"G McHugh","year":"2017","unstructured":"McHugh G, Simms V, Dauya E, et al. Clinical outcomes in children and adolescents initiating antiretroviral therapy in decentralized healthcare settings in Zimbabwe. J Int AIDS Soc. 2017;20:21843\u20139.","journal-title":"J Int AIDS Soc"},{"key":"860_CR53","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1089\/apc.2013.0345","volume":"28","author":"BC Zanoni","year":"2014","unstructured":"Zanoni BC, Mayer KH. The adolescent and young adult HIV cascade of care in the united states: exaggerated health disparities. AIDS Patient Care STDS. 2014;28:128\u201335.","journal-title":"AIDS Patient Care STDS"},{"key":"860_CR54","doi-asserted-by":"crossref","unstructured":"Maskew M, Fox MP, Evans D et al. Insights into adherence among a cohort of adolescents aged 12\u201320 years in South Africa: reported barriers to antiretroviral treatment. AIDS Res Treat. 2016; 2016:1\u201312.","DOI":"10.1155\/2016\/4161738"},{"key":"860_CR55","doi-asserted-by":"publisher","first-page":"21682","DOI":"10.3402\/gha.v6i0.21682","volume":"6","author":"G Alvarez-Uria","year":"2013","unstructured":"Alvarez-Uria G, Naik PK, Pakam R, et al. Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India. Glob Health Action. 2013;6:21682\u20138.","journal-title":"Glob Health Action"},{"key":"860_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-0500-6-512","volume":"6","author":"CE Bekolo","year":"2013","unstructured":"Bekolo CE, Webster J, Batenganya M, Sume GE, Kollo B. Trends in mortality and loss to follow-up in HIV care at the Nkongsamba regional hospital, Cameroon. BMC Res Notes. 2013;6:1\u20136. http:\/\/www.biomedcentral.com\/1756-0500\/6\/512.","journal-title":"BMC Res Notes"},{"issue":"4","key":"860_CR57","doi-asserted-by":"publisher","first-page":"e0266438","DOI":"10.1371\/journal.pone.0266438","volume":"17","author":"SY Hong","year":"2022","unstructured":"Hong SY, Winston A, Mutenda N, Hamunime N, Roy T, Wanke C, Tang AM, Jordan MR. Predictors of loss to follow-up from HIV antiretroviral therapy in Namibia. PLoS ONE. 2022;17(4):e0266438. https:\/\/doi.org\/10.1371\/journal.pone.0266438.","journal-title":"PLoS ONE"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-026-00860-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-026-00860-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-026-00860-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T14:25:35Z","timestamp":1774016735000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12981-026-00860-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["860"],"URL":"https:\/\/doi.org\/10.1186\/s12981-026-00860-x","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]},"assertion":[{"value":"25 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As this study utilized secondary data extracted from previously published studies, ethical approval and informed consent were not required. The study protocol was registered in the PROSPERO database (ID: CRD42024584420) and conducted in accordance with the PRISMA guidelines to ensure methodological transparency and rigor.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}